BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE was reported 397 times

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EYE FLAT BLEB 2 1.0000
1 VASCULAR ACCESS SITE INJURY 2 0.2500
2 CONJUNCTIVAL FILTERING BLEB LEAK 2 0.0526
3 GLAUCOMATOUS OPTIC NEUROPATHY 1 0.0500
4 CONJUNCTIVAL PAPILLAE 1 0.0500
5 VASCULAR ACCESS SITE BRUISING 2 0.0370
6 RETINOPATHY HAEMORRHAGIC 2 0.0303
7 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 2 0.0274
8 CORNEAL TOXICITY 3 0.0270
9 NERVE DEGENERATION 4 0.0222
10 IDIOPATHIC ORBITAL INFLAMMATION 4 0.0208
11 KERATITIS INTERSTITIAL 1 0.0196
12 CATHETER SITE SCAR 1 0.0167
13 CORNEAL LEUKOMA 1 0.0167
14 PRODUCT STERILITY ISSUE 2 0.0163
15 CHORIORETINAL FOLDS 1 0.0141
16 HISTOLOGY ABNORMAL 3 0.0136
17 CATARACT CORTICAL 2 0.0134
18 EYE INFECTION INTRAOCULAR 1 0.0128
19 KERATOMILEUSIS 3 0.0117
20 CONJUNCTIVITIS VIRAL 3 0.0113
21 OCULAR SURFACE DISEASE 3 0.0107
22 ADMINISTRATION SITE WOUND 1 0.0101
23 DIALYSIS HYPOTENSION 1 0.0101
24 PERSISTENT CORNEAL EPITHELIAL DEFECT 1 0.0085
25 IRIS NEOVASCULARISATION 1 0.0080
26 CRUSH INJURY 1 0.0078
27 CORNEAL EROSION 4 0.0074
28 EYELID INFECTION 3 0.0068
29 CORNEAL INFILTRATES 2 0.0064
30 RETINAL DRUSEN 1 0.0061
31 SEPTIC ENCEPHALOPATHY 1 0.0058
32 ILLOGICAL THINKING 1 0.0053
33 CONJUNCTIVAL DISORDER 2 0.0052
34 OCULAR PROCEDURAL COMPLICATION 1 0.0052
35 VESSEL PUNCTURE SITE BRUISE 1 0.0050
36 IMPLANTATION COMPLICATION 1 0.0048
37 OESOPHAGEAL ACHALASIA 3 0.0047
38 HEART VALVE OPERATION 2 0.0046
39 LASER THERAPY 1 0.0044
40 MEIBOMIAN GLAND DYSFUNCTION 2 0.0044
41 CORNEAL OPACITY 6 0.0044
42 SCLERITIS 7 0.0044
43 PRODUCT DESIGN ISSUE 3 0.0042
44 MACULAR DETACHMENT 1 0.0041
45 CORNEAL DEGENERATION 1 0.0041
46 CORNEAL THINNING 1 0.0039
47 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
48 HYPHAEMA 2 0.0038
49 PROCTITIS ULCERATIVE 2 0.0033
50 OPEN ANGLE GLAUCOMA 2 0.0033
51 CHALAZION 2 0.0031
52 PRODUCT CLOSURE REMOVAL DIFFICULT 3 0.0029
53 SINUSITIS BACTERIAL 3 0.0028
54 INSTILLATION SITE PRURITUS 1 0.0027
55 SURGICAL FAILURE 3 0.0026
56 VASCULAR ACCESS COMPLICATION 2 0.0025
57 MALIGNANT HYPERTENSION 2 0.0023
58 MANTLE CELL LYMPHOMA RECURRENT 1 0.0023
59 LENTICULAR OPACITIES 1 0.0023
60 CORNEAL OEDEMA 5 0.0022
61 CHORIORETINOPATHY 3 0.0021
62 INFUSION SITE NODULE 2 0.0021
63 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
64 SUSPECTED PRODUCT CONTAMINATION 2 0.0020
65 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 4 0.0020
66 RENAL MASS 4 0.0019
67 INFUSION SITE CELLULITIS 1 0.0019
68 INSTILLATION SITE ERYTHEMA 1 0.0019
69 RENAL NEOPLASM 4 0.0019
70 OPHTHALMIC HERPES SIMPLEX 1 0.0017
71 OPTIC NERVE INJURY 2 0.0017
72 CORNEAL EPITHELIUM DEFECT 1 0.0017
73 DEVICE MAINTENANCE ISSUE 1 0.0017
74 EYE BURNS 1 0.0017
75 RETINAL VASCULITIS 2 0.0017
76 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
77 INFUSION SITE WARMTH 2 0.0016
78 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
79 HEPATIC INFECTION 2 0.0016
80 GINGIVAL DISCOMFORT 1 0.0015
81 PRODUCT DELIVERY MECHANISM ISSUE 8 0.0015
82 ABDOMINAL RIGIDITY 4 0.0015
83 ULCERATIVE KERATITIS 4 0.0015
84 OPHTHALMIC MIGRAINE 1 0.0014
85 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
86 FACIAL DISCOMFORT 1 0.0014
87 SYPHILIS 1 0.0014
88 ANKLE OPERATION 2 0.0014
89 CONJUNCTIVITIS ALLERGIC 2 0.0013
90 CORNEAL DEPOSITS 1 0.0013
91 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
92 IRIDOCYCLITIS 4 0.0013
93 GROWTH OF EYELASHES 1 0.0013
94 REACTION TO PRESERVATIVES 1 0.0012
95 OCULAR VASCULAR DISORDER 1 0.0012
96 INTRAOCULAR PRESSURE INCREASED 15 0.0012
97 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
98 VASOCONSTRICTION 1 0.0011
99 INFUSION SITE DISCHARGE 2 0.0011
100 CONJUNCTIVAL HYPERAEMIA 4 0.0011
101 LIGAMENT DISORDER 1 0.0011
102 VENTRICULAR ARRHYTHMIA 4 0.0011
103 PUNCTATE KERATITIS 1 0.0011
104 CATHETER SITE SWELLING 1 0.0011
105 SCROTAL SWELLING 1 0.0011
106 PRODUCT AFTER TASTE 1 0.0010
107 PRINZMETAL ANGINA 1 0.0010
108 OCULAR DISCOMFORT 11 0.0010
109 CONJUNCTIVAL OEDEMA 1 0.0010
110 DEVICE MATERIAL ISSUE 2 0.0010
111 AMAUROSIS FUGAX 1 0.0009
112 SUPERFICIAL INJURY OF EYE 1 0.0009
113 INFUSION SITE HAEMORRHAGE 3 0.0009
114 PRODUCT LOT NUMBER ISSUE 2 0.0009
115 EYELID DISORDER 2 0.0009
116 INFUSION SITE INFECTION 2 0.0009
117 INSTILLATION SITE IRRITATION 1 0.0008
118 PENILE SWELLING 1 0.0008
119 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
120 TENDON INJURY 3 0.0008
121 DEVICE INFUSION ISSUE 2 0.0008
122 EYELID IRRITATION 2 0.0008
123 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
124 CARBON DIOXIDE INCREASED 1 0.0007
125 EYE INFLAMMATION 7 0.0007
126 CORNEAL ABRASION 1 0.0007
127 IMMUNOGLOBULINS DECREASED 1 0.0007
128 PERIORBITAL SWELLING 4 0.0007
129 INVESTIGATION ABNORMAL 1 0.0007
130 SEBORRHOEIC KERATOSIS 1 0.0007
131 STRESS CARDIOMYOPATHY 4 0.0007
132 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
133 INFUSION SITE INDURATION 1 0.0007
134 KERATITIS 2 0.0007
135 EYE ALLERGY 1 0.0006
136 RENAL CYST 5 0.0006
137 FOREIGN BODY SENSATION IN EYES 4 0.0006
138 AORTIC VALVE DISEASE 1 0.0006
139 INJECTION RELATED REACTION 1 0.0006
140 UVEITIS 8 0.0006
141 RETINITIS 1 0.0006
142 METASTASIS 4 0.0006
143 PRODUCT TAMPERING 1 0.0006
144 ERYTHEMA OF EYELID 3 0.0006
145 DEVICE ALARM ISSUE 1 0.0006
146 OCULAR HYPERAEMIA 26 0.0005
147 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
148 VITRITIS 1 0.0005
149 EYE PAIN 30 0.0005
150 PHOTOPHOBIA 10 0.0005
151 CYSTOID MACULAR OEDEMA 1 0.0005
152 SACROILIITIS 1 0.0005
153 GLAUCOMA 10 0.0005
154 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
155 HYPERAEMIA 1 0.0005
156 EYE IRRITATION 29 0.0005
157 HYPOPHYSITIS 1 0.0005
158 EYELID PAIN 1 0.0005
159 SKIN INDURATION 1 0.0005
160 ATRIAL TACHYCARDIA 1 0.0005
161 OPTIC NEUROPATHY 1 0.0005
162 TORTICOLLIS 1 0.0005
163 CATHETER SITE ERYTHEMA 1 0.0005
164 ABNORMAL SENSATION IN EYE 2 0.0005
165 INFUSION SITE BRUISING 1 0.0005
166 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
167 READING DISORDER 1 0.0004
168 CONJUNCTIVITIS 8 0.0004
169 LYMPHADENITIS 1 0.0004
170 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
171 INSTILLATION SITE PAIN 1 0.0004
172 OSTEITIS 1 0.0004
173 INFUSION SITE PAIN 5 0.0004
174 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
175 CLUMSINESS 1 0.0004
176 ASTHENOPIA 2 0.0004
177 RASH MORBILLIFORM 1 0.0004
178 INFUSION SITE ERYTHEMA 3 0.0004
179 NEUTROPHIL COUNT ABNORMAL 1 0.0004
180 PRODUCT CONTAINER ISSUE 3 0.0003
181 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
182 TOOTH DISCOLOURATION 1 0.0003
183 EYE INJURY 1 0.0003
184 EYE PRURITUS 11 0.0003
185 DIABETIC FOOT 1 0.0003
186 MIDDLE INSOMNIA 6 0.0003
187 EYELIDS PRURITUS 1 0.0003
188 SWELLING OF EYELID 2 0.0003
189 INFUSION SITE SWELLING 2 0.0003
190 INFUSION SITE PRURITUS 1 0.0003
191 RECALLED PRODUCT ADMINISTERED 3 0.0003
192 EYE DISCHARGE 3 0.0003
193 FACIAL PARESIS 1 0.0003
194 PRODUCT CONTAMINATION 1 0.0003
195 DEVICE KINK 1 0.0003
196 EYE DISORDER 9 0.0003
197 RETINOPATHY 1 0.0003
198 EYE INFECTION 3 0.0003
199 CATHETER SITE INFECTION 1 0.0003
200 HERNIA 5 0.0003
201 SPINAL PAIN 3 0.0003
202 BLEPHARITIS 1 0.0002
203 SENSORY DISTURBANCE 4 0.0002
204 BLINDNESS 10 0.0002
205 ENCEPHALOPATHY 6 0.0002
206 MYDRIASIS 3 0.0002
207 GINGIVAL SWELLING 1 0.0002
208 IRON DEFICIENCY 1 0.0002
209 ANAL INCONTINENCE 2 0.0002
210 OROPHARYNGEAL DISCOMFORT 2 0.0002
211 RETINAL DETACHMENT 2 0.0002
212 EYE OPERATION 1 0.0002
213 BLINDNESS UNILATERAL 3 0.0002
214 VAGINAL INFECTION 1 0.0002
215 FINGER DEFORMITY 1 0.0002
216 ORGANISING PNEUMONIA 1 0.0002
217 PROTEIN URINE PRESENT 1 0.0002
218 HYPOTONIA 2 0.0002
219 HEART RATE DECREASED 7 0.0002
220 LACRIMATION INCREASED 6 0.0002
221 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
222 POOR VENOUS ACCESS 2 0.0002
223 THERAPY PARTIAL RESPONDER 3 0.0002
224 PRODUCT SUBSTITUTION ISSUE 11 0.0002
225 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
226 FOOD POISONING 1 0.0002
227 STRESS FRACTURE 1 0.0002
228 INJECTION SITE INJURY 1 0.0002
229 HEART RATE ABNORMAL 1 0.0002
230 MACULAR OEDEMA 1 0.0002
231 PRODUCT LEAKAGE 1 0.0002
232 HEART RATE IRREGULAR 4 0.0002
233 SCAB 2 0.0002
234 RHEUMATOID FACTOR POSITIVE 1 0.0002
235 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
236 VISUAL IMPAIRMENT 21 0.0002
237 ENDOPHTHALMITIS 1 0.0002
238 TOOTHACHE 3 0.0002
239 PLATELET COUNT ABNORMAL 1 0.0002
240 PNEUMONIA ASPIRATION 4 0.0002
241 FRACTURE 3 0.0002
242 FEELING JITTERY 3 0.0002
243 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
244 EXTRA DOSE ADMINISTERED 6 0.0001
245 FREQUENT BOWEL MOVEMENTS 4 0.0001
246 WRONG PRODUCT ADMINISTERED 1 0.0001
247 PRODUCT LABEL ISSUE 1 0.0001
248 PALLOR 4 0.0001
249 JOINT EFFUSION 1 0.0001
250 DELIRIUM 5 0.0001
251 SEASONAL ALLERGY 2 0.0001
252 DRY EYE 7 0.0001
253 PRODUCT SUPPLY ISSUE 1 0.0001
254 PRODUCT PRESCRIBING ISSUE 3 0.0001
255 TRANSAMINASES INCREASED 3 0.0001
256 PULMONARY OEDEMA 6 0.0001
257 BRADYCARDIA 7 0.0001
258 DEVICE FAILURE 2 0.0001
259 VISION BLURRED 18 0.0001
260 FOOD ALLERGY 1 0.0001
261 PELVIC FRACTURE 1 0.0001
262 HAEMORRHAGIC STROKE 1 0.0001
263 BONE DENSITY DECREASED 4 0.0001
264 MULTIPLE ALLERGIES 1 0.0001
265 FURUNCLE 1 0.0001
266 GINGIVAL PAIN 1 0.0001
267 MOVEMENT DISORDER 4 0.0001
268 STENT PLACEMENT 1 0.0001
269 MYASTHENIA GRAVIS 1 0.0001
270 ACUTE CORONARY SYNDROME 1 0.0001
271 HEMIPLEGIA 1 0.0001
272 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
273 SKIN SWELLING 1 0.0001
274 HAEMOLYTIC ANAEMIA 1 0.0001
275 GOUT 2 0.0001
276 UROSEPSIS 1 0.0001
277 RHINORRHOEA 7 0.0001
278 NECK PAIN 6 0.0001
279 ERYTHEMA MULTIFORME 1 0.0001
280 APPENDICITIS 1 0.0001
281 OXYGEN SATURATION DECREASED 6 0.0001
282 FLANK PAIN 1 0.0001
283 DYSPNOEA EXERTIONAL 4 0.0001
284 BLOOD SODIUM DECREASED 2 0.0001
285 INFUSION RELATED REACTION 7 0.0001
286 SPUTUM DISCOLOURED 1 0.0001
287 PRODUCT PACKAGING ISSUE 1 0.0001
288 SINUS BRADYCARDIA 1 0.0001
289 VITREOUS FLOATERS 1 0.0001
290 KNEE OPERATION 1 0.0001
291 CATARACT 6 0.0001
292 SALIVARY HYPERSECRETION 1 0.0001
293 POOR QUALITY DEVICE USED 1 0.0001
294 TOXIC SKIN ERUPTION 1 0.0001
295 PRODUCT ADMINISTRATION ERROR 2 0.0001
296 EYELID PTOSIS 1 0.0001
297 INFLAMMATION 5 0.0001
298 WEIGHT FLUCTUATION 1 0.0001
299 SKIN CANCER 2 0.0001
300 AMNESIA 6 0.0001
301 DIABETES MELLITUS 7 0.0001
302 BLOOD PRESSURE INCREASED 14 0.0001
303 DENTAL CARIES 1 0.0001
304 NERVE INJURY 1 0.0001
305 THERAPY NON-RESPONDER 4 0.0001
306 MYOCARDIAL ISCHAEMIA 1 0.0001
307 DERMATITIS CONTACT 1 0.0001
308 PERICARDIAL EFFUSION 2 0.0001
309 MADAROSIS 1 0.0001
310 EYELID OEDEMA 1 0.0001
311 VASCULITIS 1 0.0001
312 NASAL CONGESTION 5 0.0001
313 COVID-19 PNEUMONIA 1 0.0001
314 MACULAR DEGENERATION 1 0.0001
315 LOCALISED INFECTION 2 0.0001
316 BURSITIS 1 0.0001
317 PRESYNCOPE 2 0.0001
318 INJECTION SITE MASS 3 0.0001
319 TENDON RUPTURE 1 0.0001
320 HEART RATE INCREASED 8 0.0001
321 CYST 1 0.0001
322 MUSCLE ATROPHY 1 0.0001
323 ROTATOR CUFF SYNDROME 1 0.0001
324 ORAL CANDIDIASIS 1 0.0001
325 ANKYLOSING SPONDYLITIS 1 0.0001
326 TOOTH INFECTION 1 0.0001
327 EYE HAEMORRHAGE 1 0.0001
328 PRODUCT DOSE OMISSION ISSUE 22 0.0001
329 HYPOTENSION 15 0.0001
330 JOINT RANGE OF MOTION DECREASED 1 0.0001
331 IMPAIRED GASTRIC EMPTYING 1 0.0001
332 ANAPHYLACTIC REACTION 4 0.0001
333 ORAL DISCOMFORT 1 0.0001
334 POLLAKIURIA 3 0.0001
335 CARPAL TUNNEL SYNDROME 1 0.0001
336 PAIN IN JAW 2 0.0001
337 INTENTIONAL DOSE OMISSION 2 0.0001
338 RED BLOOD CELL COUNT DECREASED 2 0.0001
339 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
340 ASCITES 2 0.0001
341 URINARY INCONTINENCE 2 0.0001
342 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
343 SKIN HAEMORRHAGE 1 0.0001
344 COLON CANCER 1 0.0001
345 IMMUNODEFICIENCY 1 0.0001
346 RESPIRATORY DISORDER 2 0.0001
347 INSURANCE ISSUE 1 0.0001
348 DEVICE ADHESION ISSUE 1 0.0001
349 THYROID DISORDER 1 0.0001
350 MUSCULOSKELETAL CHEST PAIN 1 0.0001
351 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
352 BRAIN FOG 1 0.0001
353 RESPIRATORY TRACT CONGESTION 1 0.0001
354 ABSCESS 1 0.0001
355 SWELLING FACE 4 0.0001
356 HYPERTENSION 13 0.0001
357 CHOLELITHIASIS 2 0.0001
358 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
359 VISUAL ACUITY REDUCED 2 0.0001
360 THERAPY CESSATION 3 0.0001
361 BALANCE DISORDER 5 0.0001
362 DEVICE DEFECTIVE 1 0.0001
363 NEOPLASM PROGRESSION 2 0.0001
364 ABDOMINAL DISTENSION 6 0.0001
365 OFF LABEL USE 50 0.0001
366 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
367 EOSINOPHILIA 1 0.0001
368 COVID-19 10 0.0001
369 HEAD DISCOMFORT 1 0.0001
370 GASTROENTERITIS VIRAL 1 0.0001
371 OSTEOMYELITIS 1 0.0001
372 AGITATION 4 0.0001
373 DYSURIA 2 0.0001
374 EYE SWELLING 2 0.0001
375 HALLUCINATION 4 0.0001
376 FLATULENCE 3 0.0001
377 DEHYDRATION 7 0.0001
378 POST PROCEDURAL COMPLICATION 1 0.0001
379 CONTUSION 5 0.0001
380 ERUCTATION 1 0.0001
381 PLASMA CELL MYELOMA 2 0.0001
382 ORAL HERPES 1 0.0001
383 SKIN FISSURES 1 0.0001
384 FALL 17 0.0001
385 HAEMATOCRIT DECREASED 1 0.0001
386 UPPER LIMB FRACTURE 1 0.0001
387 CYTOKINE RELEASE SYNDROME 1 0.0000
388 DRY MOUTH 4 0.0000
389 INJURY ASSOCIATED WITH DEVICE 1 0.0000
390 BODY TEMPERATURE INCREASED 1 0.0000
391 NASOPHARYNGITIS 9 0.0000
392 RIB FRACTURE 1 0.0000
393 TREATMENT FAILURE 4 0.0000
394 DERMATITIS 1 0.0000
395 PAIN IN EXTREMITY 14 0.0000
396 RETCHING 1 0.0000
397 POOR QUALITY SLEEP 1 0.0000
398 DEEP VEIN THROMBOSIS 3 0.0000
399 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
400 FAECES DISCOLOURED 1 0.0000
401 DEVICE DISLOCATION 2 0.0000
402 PRODUCT DOSE OMISSION 3 0.0000
403 BLOOD CREATININE INCREASED 3 0.0000
404 PRODUCT DISPENSING ERROR 1 0.0000
405 ANGIOEDEMA 2 0.0000
406 LIVER DISORDER 2 0.0000
407 ORAL PAIN 1 0.0000
408 PRODUCT AVAILABILITY ISSUE 1 0.0000
409 SKIN IRRITATION 2 0.0000
410 CONFUSIONAL STATE 7 0.0000
411 COGNITIVE DISORDER 2 0.0000
412 PALPITATIONS 5 0.0000
413 CHILLS 5 0.0000
414 PRODUCTIVE COUGH 2 0.0000
415 SKIN BURNING SENSATION 3 0.0000
416 BLOOD PRESSURE FLUCTUATION 1 0.0000
417 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
418 CEREBROVASCULAR ACCIDENT 7 0.0000
419 NEURALGIA 1 0.0000
420 OEDEMA PERIPHERAL 5 0.0000
421 PNEUMONIA 13 0.0000
422 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
423 INCORRECT DOSE ADMINISTERED 9 0.0000
424 WEIGHT DECREASED 11 0.0000
425 COUGH 11 0.0000
426 HYPOPHAGIA 1 0.0000
427 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
428 SINUSITIS 4 0.0000
429 PERIPHERAL SWELLING 6 0.0000
430 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
431 BACK PAIN 9 0.0000
432 HAEMATOMA 1 0.0000
433 EXPOSURE VIA SKIN CONTACT 1 0.0000
434 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
435 JOINT STIFFNESS 1 0.0000
436 PANCREATITIS 2 0.0000
437 DEPRESSED MOOD 2 0.0000
438 HYPERSENSITIVITY 7 0.0000
439 EAR INFECTION 1 0.0000
440 MEMORY IMPAIRMENT 5 0.0000
441 CONDITION AGGRAVATED 11 0.0000
442 PROCEDURAL PAIN 1 0.0000
443 ARTHROPATHY 2 0.0000
444 HYPONATRAEMIA 2 0.0000
445 ASTHMA 4 0.0000
446 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
447 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
448 HERPES ZOSTER 2 0.0000
449 LETHARGY 2 0.0000
450 INFECTION 5 0.0000
451 NEEDLE ISSUE 1 0.0000
452 ACUTE MYOCARDIAL INFARCTION 1 0.0000
453 WHEEZING 2 0.0000
454 BLOOD POTASSIUM DECREASED 1 0.0000
455 JOINT SWELLING 4 0.0000
456 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
457 VERTIGO 2 0.0000
458 DISCOMFORT 2 0.0000
459 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
460 SWELLING 3 0.0000
461 PRODUCT USE ISSUE 6 0.0000
462 HEADACHE 20 0.0000
463 DRUG-INDUCED LIVER INJURY 1 0.0000
464 FATIGUE 24 0.0000
465 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
466 BLOOD PRESSURE DECREASED 2 0.0000
467 EXPIRED PRODUCT ADMINISTERED 1 0.0000
468 DRY SKIN 4 0.0000
469 ANGER 1 0.0000
470 PRODUCT QUALITY ISSUE 4 0.0000
471 HAEMOGLOBIN DECREASED 3 0.0000
472 ERYTHEMA 6 0.0000
473 HYPOXIA 1 0.0000
474 PLATELET COUNT DECREASED 3 0.0000
475 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
476 DIZZINESS 14 0.0000
477 PAIN 17 0.0000
478 C-REACTIVE PROTEIN INCREASED 1 0.0000
479 HYPERGLYCAEMIA 1 0.0000
480 MUSCLE SPASMS 5 0.0000
481 EPISTAXIS 2 0.0000
482 HOT FLUSH 2 0.0000
483 BLOOD GLUCOSE INCREASED 5 0.0000
484 MUSCULAR WEAKNESS 3 0.0000
485 ACNE 2 0.0000
486 INSOMNIA 7 0.0000
487 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
488 ARTHRITIS 2 0.0000
489 DYSKINESIA 1 0.0000
490 NEUTROPHIL COUNT DECREASED 1 0.0000
491 OSTEOPOROSIS 1 0.0000
492 ABDOMINAL PAIN UPPER 5 0.0000
493 OSTEOARTHRITIS 1 0.0000
494 URINARY TRACT INFECTION 4 0.0000
495 HYPOACUSIS 1 0.0000
496 DEVICE LEAKAGE 1 0.0000
497 PRODUCT STORAGE ERROR 2 0.0000
498 MUSCULOSKELETAL STIFFNESS 2 0.0000
499 MALAISE 10 0.0000
500 NAUSEA 18 0.0000
501 THROAT IRRITATION 1 0.0000
502 DRUG INEFFECTIVE 29 0.0000
503 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
504 RENAL DISORDER 1 0.0000
505 CARDIAC DISORDER 2 0.0000
506 ARRHYTHMIA 1 0.0000
507 DYSPHAGIA 2 0.0000
508 PULMONARY EMBOLISM 2 0.0000
509 MIGRAINE 2 0.0000
510 SYNCOPE 2 0.0000
511 SOMNOLENCE 4 0.0000
512 CELLULITIS 1 0.0000
513 FLUID RETENTION 1 0.0000
514 DYSPNOEA 11 0.0000
515 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
516 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
517 NERVOUSNESS 1 0.0000
518 SPEECH DISORDER 1 0.0000
519 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
520 PRURITUS 7 0.0000
521 WEIGHT INCREASED 4 0.0000
522 MYALGIA 3 0.0000
523 DEPRESSION 4 0.0000
524 ANXIETY 5 0.0000
525 DYSPHONIA 1 0.0000
526 ARTHRALGIA 7 0.0000
527 FEELING ABNORMAL 4 0.0000
528 THERAPEUTIC RESPONSE DECREASED 1 0.0000
529 PLEURAL EFFUSION 1 0.0000
530 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
531 CHEST PAIN 3 0.0000
532 HYPERHIDROSIS 2 0.0000
533 VOMITING 7 0.0000
534 HEPATIC ENZYME INCREASED 1 0.0000
535 BURNING SENSATION 1 0.0000
536 THERAPY INTERRUPTED 1 0.0000
537 DIARRHOEA 9 0.0000
538 RASH 6 0.0000
539 CONSTIPATION 3 0.0000
540 UNDERDOSE 1 0.0000
541 DYSGEUSIA 1 0.0000
542 ASTHENIA 5 0.0000
543 INJECTION SITE SWELLING 1 0.0000
544 DECREASED APPETITE 3 0.0000
545 INJECTION SITE HAEMORRHAGE 1 0.0000
546 CARDIAC FAILURE CONGESTIVE 1 0.0000
547 THROMBOSIS 1 0.0000
548 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
549 INFLUENZA LIKE ILLNESS 1 0.0000
550 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
551 ABDOMINAL DISCOMFORT 2 0.0000
552 SKIN EXFOLIATION 1 0.0000
553 GASTROINTESTINAL DISORDER 1 0.0000
554 DEVICE ISSUE 1 0.0000
555 NO ADVERSE EVENT 2 0.0000
556 OROPHARYNGEAL PAIN 1 0.0000
557 NEUROPATHY PERIPHERAL 1 0.0000
558 DRUG INTOLERANCE 1 0.0000
559 ATRIAL FIBRILLATION 1 0.0000
560 DYSPEPSIA 1 0.0000
561 FLUSHING 1 0.0000
562 CHEST DISCOMFORT 1 0.0000
563 ILLNESS 1 0.0000
564 DEATH 8 0.0000
565 THROMBOCYTOPENIA 1 0.0000
566 RHEUMATOID ARTHRITIS 1 0.0000
567 PYREXIA 3 0.0000
568 ABDOMINAL PAIN 2 0.0000
569 LOSS OF CONSCIOUSNESS 1 0.0000
570 RENAL FAILURE 1 0.0000
571 HYPOAESTHESIA 1 0.0000
572 PARAESTHESIA 1 0.0000
573 URTICARIA 1 0.0000
574 ANAEMIA 1 0.0000
575 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
576 OVERDOSE 1 0.0000
577 INJECTION SITE PAIN 1 0.0000